ArticleCurrent journal of neurology2020
The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
Rahil Sadat Shahtaheri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2020
this paperpooled itcites it